Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1997 Apr;62(4):361–366. doi: 10.1136/jnnp.62.4.361

Spinal and cutaneous schwannomatosis is a variant form of type 2 neurofibromatosis: a clinical and molecular study.

D G Evans 1, S Mason 1, S M Huson 1, M Ponder 1, A E Harding 1, T Strachan 1
PMCID: PMC1074092  PMID: 9120449

Abstract

OBJECTIVE: To delineate the clinical phenotype, molecular basis, and implications for screening in patients and families with multiple schwannomas not generally involving the cranium. METHODS: As part of a United Kingdom clinical and genetic study of type 2 neurofibromatosis (NF2) patients and families with multiple schwannomas who do not fulfil diagnostic criteria for NF2 have been identified. The clinical phenotype was studied in the extended families and molecular analysis was carried out at the NF2 gene locus on chromosome 22. RESULTS: Patterns of inheritance in five families with schwannomatosis are consistent with inheritance of an autosomal dominant gene. The consistency of phenotype, with relative sparing of the cranium, is constant in these families. However, families which initially seem to be indicative of schwannomatosis may develop into classic NF2 as shown by a sixth family. Many of the tumours found in these families were referred to as "neurofibroma" when they were clearly schwannomas. This difference in classification has major implications for the relative risk of each particular type of neurofibromatosis and neuropathological review may be important in some cases. Genetic linkage analysis in the two largest families is entirely consistent with primary involvement of the NF2 gene. CONCLUSIONS: Variant forms of neurofibromatosis have presented a dilemma in classification and determination of recurrence risks in families. Previous reports have suggested that schwannomatosis is a sporadic non-hereditary condition. Patients with multiple schwannomas are likely to have a variant form of NF2 and up to a 50% risk of passing on a gene predisposing to multiple schwannoma.

Full text

PDF
363

Images in this article

362Image
on p.362
362Image
on p.362

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bourn D., Strachan T. Dinucleotide repeat polymorphism at the NF2 gene. Hum Mol Genet. 1994 Oct;3(10):1914–1914. doi: 10.1093/hmg/3.10.1914. [DOI] [PubMed] [Google Scholar]
  2. Evans D. G., Bourn D., Wallace A., Ramsden R. T., Mitchell J. D., Strachan T. Diagnostic issues in a family with late onset type 2 neurofibromatosis. J Med Genet. 1995 Jun;32(6):470–474. doi: 10.1136/jmg.32.6.470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Evans D. G., Huson S. M., Donnai D., Neary W., Blair V., Newton V., Harris R. A clinical study of type 2 neurofibromatosis. Q J Med. 1992 Aug;84(304):603–618. [PubMed] [Google Scholar]
  4. Evans D. G., Huson S. M., Donnai D., Neary W., Blair V., Newton V., Strachan T., Harris R. A genetic study of type 2 neurofibromatosis in the United Kingdom. II. Guidelines for genetic counselling. J Med Genet. 1992 Dec;29(12):847–852. doi: 10.1136/jmg.29.12.847. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Evans D. G., Huson S. M., Donnai D., Neary W., Blair V., Teare D., Newton V., Strachan T., Ramsden R., Harris R. A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity. J Med Genet. 1992 Dec;29(12):841–846. doi: 10.1136/jmg.29.12.841. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Fisher E. R., Vuzevski V. D. Cytogenesis of schwannoma (neurilemoma), neurofibroma, dermatofibroma, and dermatofibrosarcoma as revealed by electron microscopy. Am J Clin Pathol. 1968 Feb;49(2):141–154. doi: 10.1093/ajcp/49.2.141. [DOI] [PubMed] [Google Scholar]
  7. Honda M., Arai E., Sawada S., Ohta A., Niimura M. Neurofibromatosis 2 and neurilemmomatosis gene are identical. J Invest Dermatol. 1995 Jan;104(1):74–77. doi: 10.1111/1523-1747.ep12613537. [DOI] [PubMed] [Google Scholar]
  8. Izumi A. K., Rosato F. E., Wood M. G. Von Recklinghausen's disease associated with multiple neurolemomas. Arch Dermatol. 1971 Aug;104(2):172–176. [PubMed] [Google Scholar]
  9. Kanter W. R., Eldridge R., Fabricant R., Allen J. C., Koerber T. Central neurofibromatosis with bilateral acoustic neuroma: genetic, clinical and biochemical distinctions from peripheral neurofibromatosis. Neurology. 1980 Aug;30(8):851–859. doi: 10.1212/wnl.30.8.851. [DOI] [PubMed] [Google Scholar]
  10. MacCollin M., Woodfin W., Kronn D., Short M. P. Schwannomatosis: a clinical and pathologic study. Neurology. 1996 Apr;46(4):1072–1079. doi: 10.1212/wnl.46.4.1072. [DOI] [PubMed] [Google Scholar]
  11. Marineau C., Baron C., Delattre O., Zucman J., Thomas G., Rouleau G. A. Dinucleotide repeat polymorphism at the D22S268 locus. Hum Mol Genet. 1993 Mar;2(3):336–336. doi: 10.1093/hmg/2.3.336-a. [DOI] [PubMed] [Google Scholar]
  12. Mérel P., Hoang-Xuan K., Sanson M., Bijlsma E., Rouleau G., Laurent-Puig P., Pulst S., Baser M., Lenoir G., Sterkers J. M. Screening for germ-line mutations in the NF2 gene. Genes Chromosomes Cancer. 1995 Feb;12(2):117–127. doi: 10.1002/gcc.2870120206. [DOI] [PubMed] [Google Scholar]
  13. Pulst S. M., Riccardi V. M., Fain P., Korenberg J. R. Familial spinal neurofibromatosis: clinical and DNA linkage analysis. Neurology. 1991 Dec;41(12):1923–1927. doi: 10.1212/wnl.41.12.1923. [DOI] [PubMed] [Google Scholar]
  14. Purcell S. M., Dixon S. L. Schwannomatosis. An unusual variant of neurofibromatosis or a distinct clinical entity? Arch Dermatol. 1989 Mar;125(3):390–393. doi: 10.1001/archderm.125.3.390. [DOI] [PubMed] [Google Scholar]
  15. Rouleau G. A., Merel P., Lutchman M., Sanson M., Zucman J., Marineau C., Hoang-Xuan K., Demczuk S., Desmaze C., Plougastel B. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature. 1993 Jun 10;363(6429):515–521. doi: 10.1038/363515a0. [DOI] [PubMed] [Google Scholar]
  16. Rouleau G. A., Wertelecki W., Haines J. L., Hobbs W. J., Trofatter J. A., Seizinger B. R., Martuza R. L., Superneau D. W., Conneally P. M., Gusella J. F. Genetic linkage of bilateral acoustic neurofibromatosis to a DNA marker on chromosome 22. Nature. 1987 Sep 17;329(6136):246–248. doi: 10.1038/329246a0. [DOI] [PubMed] [Google Scholar]
  17. Sainz J., Nechiporuk A., Kim U. J., Simon M. I., Pulst S. M. CA-repeat polymorphism at the D22S430 locus adjacent to NF2. Hum Mol Genet. 1993 Dec;2(12):2203–2203. doi: 10.1093/hmg/2.12.2203. [DOI] [PubMed] [Google Scholar]
  18. Seizinger B. R., Rouleau G. A., Ozelius L. J., Lane A. H., Faryniarz A. G., Chao M. V., Huson S., Korf B. R., Parry D. M., Pericak-Vance M. A. Genetic linkage of von Recklinghausen neurofibromatosis to the nerve growth factor receptor gene. Cell. 1987 Jun 5;49(5):589–594. doi: 10.1016/0092-8674(87)90534-4. [DOI] [PubMed] [Google Scholar]
  19. Shishiba T., Niimura M., Ohtsuka F., Tsuru N. Multiple cutaneous neurilemmomas as a skin manifestation of neurilemmomatosis. J Am Acad Dermatol. 1984 May;10(5 Pt 1):744–754. doi: 10.1016/s0190-9622(84)70089-2. [DOI] [PubMed] [Google Scholar]
  20. Trofatter J. A., MacCollin M. M., Rutter J. L., Murrell J. R., Duyao M. P., Parry D. M., Eldridge R., Kley N., Menon A. G., Pulaski K. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell. 1993 Mar 12;72(5):791–800. doi: 10.1016/0092-8674(93)90406-g. [DOI] [PubMed] [Google Scholar]
  21. Weissenbach J., Gyapay G., Dib C., Vignal A., Morissette J., Millasseau P., Vaysseix G., Lathrop M. A second-generation linkage map of the human genome. Nature. 1992 Oct 29;359(6398):794–801. doi: 10.1038/359794a0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES